SCHEMBL28504698

SCHEMBL28504698

CN1CCN(c2ccc(-c3cnc4[nH]cc(-c5cc[c]cc5)c4c3)cc2F)CC1

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TNIK Q9UKE5 8/20 0.55
MAP4K1 Q92918 5/20 0.53
IL2 P60568 3/20 0.52
MAP3K11 Q16584 5/20 0.48
DYRK1A Q13627 2/20 0.47
CLK1 P49759 1/20 0.46
CLK2 P49760 1/20 0.46
DYRK2 Q92630 1/20 0.46
CLK4 Q9HAZ1 1/20 0.46
DYRK1B Q9Y463 1/20 0.46
IKBKB O14920 1/20 0.46
CHUK O15111 1/20 0.46
ABL1 P00519 1/20 0.46
INSR P06213 1/20 0.46
CDK2 P24941 1/20 0.46
FLT3 P36888 1/20 0.46
TDO2 P48775 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28504384 0.89 MAP4K1 (0.66) TNIKMAP4K1IL2MAP3K11IKBKB
SCHEMBL28504588 0.85 MAP4K1 (0.70) TNIKMAP4K1IL2MAP3K11DYRK1A
SCHEMBL21592978 0.83 MAP4K1 (0.59) TNIKMAP4K1IL2MAP3K11DYRK1A
SCHEMBL21592580 0.83 MAP4K1 (0.51) TNIKMAP4K1IL2MAP3K11DYRK1A
SCHEMBL28504625 0.83 MAP4K1 (0.53) TNIKMAP4K1IL2MAP3K11DYRK1A
SCHEMBL21592578 0.82 MAP4K1 (0.50) TNIKMAP4K1IL2MAP3K11DYRK1A
SCHEMBL21593019 0.81 MAP4K1 (0.49) TNIKMAP4K1IL2MAP3K11DYRK1A
SCHEMBL28503427 0.81 MAP4K1 (0.54) TNIKMAP4K1IL2MAP3K11IKBKB
SCHEMBL21592987 0.81 MAP4K1 (0.55) TNIKMAP4K1IL2MAP3K11DYRK1A
SCHEMBL21592875 0.81 MAP4K1 (0.56) TNIKMAP4K1IL2MAP3K11DYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112243439-A Pyrrolo [2,3-B ] pyridines or pyrrolo [2,3-B ] pyrazines as HPK1 inhibitors and uses thereof 百济神州有限公司 2021-01-19 CN disclosed